• 14 Aug 19

  SUDA’s Science Advisory Board Member, Dr Richard Franklin Joins as Project Director of Anagrelide Project

• 14 Aug 19

  New Project Director for Anagrelide Project

• 09 Aug 19

  ArTiMist Appeal Lodged with TGA

• 09 Aug 19

  SUDA welcomes Australian Goverment’s initiatives to Foster Medical Marijuana Industry

• 07 Aug 19

  SUDA Pharmaceuticals: Pharmacy and Pharmacology Journal Publishes impressive ZolpiMistTM Clinical Study Results

• 07 Aug 19

  Government Initiatives to Boost Medical Marijuana Industry

• 06 Aug 19

  ZolpiMist Clinical Results Published

• 01 Aug 19

  SUDA’s June Quarterly Report Out on ASX; A Look at its Business and Technology

• 31 Jul 19

  Appendix 4C – quarterly

• 25 Jul 19

  SUDA receives patent for the only effective medicine for platelet reduction, Anagrelide; Stock soars 33% + Editorial Calendar (Media coverage planner)